Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Mougdil, Tarsem, Feng, Zipei, Dubay, Christopher, Fisher, Brenda, Koguchi, Yoshinobu, Aung, Sandra, MedVolume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P435
File:
PDF, 253 KB
english, 2015